A prospective, single-center, case-control study assessing the effects of both inactivated and mRNA COVID-19 vaccines in patients with Systemic Lupus Erythematosus
Latest Information Update: 30 Jun 2022
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
Most Recent Events
- 30 Jun 2022 New trial record
- 04 Jun 2022 Results presented at the 23rd Annual Congress of the European League Against Rheumatism